TC BioPharm announced that the company has regained compliance with the Nasdaq Stock Market Listing Rule 5550(b) which will maintain the listing of the company’s American depositary shares on the Nasdaq Global Select Market.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>